Comerica Bank’s Ascendis Pharma A/S ASND Stock Holding History

Comerica Bank’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$18.4M	Buy	153,719 +41,112	+37%	+$4.77M	0.14%	131
2022 Q3	$12M	Buy	112,607 +3,520	+3%	+$334K	0.1%	193
2022 Q2	$9.59M	Buy	109,087 +19,610	+22%	+$1.85M	0.08%	260
2022 Q1	$9.81M	Buy	89,477 +2,027	+2%	+$235K	0.07%	287
2021 Q4	$9.93M	Buy	87,450 +19,411	+29%	+$2.89M	0.07%	272
2021 Q3	$9.84M	Sell	68,039 -4,232	-6%	-$579K	0.06%	355
2021 Q2	$8.61M	Buy	72,271 +28,180	+64%	+$3.76M	0.05%	414
2021 Q1	$5.82M	Buy	44,091 +15,143	+52%	+$2.3M	0.03%	648
2020 Q4	$4.65M	Buy	28,948 +12,125	+72%	+$2.01M	0.03%	744
2020 Q3	$2.69M	Buy	16,823 +1,617	+11%	+$232K	0.02%	924
2020 Q2	$2.17M	Buy	15,206 +1,123	+8%	+$154K	0.02%	1033
2020 Q1	$1.82M	Buy	14,083 +11,671	+484%	+$1.52M	0.02%	970
2019 Q4	$323K	Buy	2,412 +45	+2%	+$5K	﹤0.01%	2037
2019 Q3	$249K	Sell	2,367 -93	-4%	-$10.4K	﹤0.01%	2116
2019 Q2	$277K	Buy	2,460 +179	+8%	+$21.4K	﹤0.01%	2095
2019 Q1	$275K	Buy	+2,281	New	+$200K	﹤0.01%	2094

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Comerica Bank's ASND Position: Q4 2022 in Review

Comerica Bank increased its Ascendis Pharma A/S (ASND) stake by 37% in Q4 2022, buying an estimated $4.77M and bringing the position to 153,719 shares worth $18.4M. The position accounts for 0.14% of the portfolio, ranked #131.

Comerica Bank first reported a position in ASND in Q1 2019 and has held it in 16 quarters since. 187 funds tracked by Wall St. Rank hold ASND as of Q4 2022.

Comerica Bank held 153,719 shares of Ascendis Pharma A/S worth $18.4M as of Q4 2022.
Comerica Bank bought 41,112 Ascendis Pharma A/S shares in Q4 2022, an estimated $4.77M.
Ascendis Pharma A/S made up 0.14% of Comerica Bank's portfolio in Q4 2022, its #131 holding.
Comerica Bank first reported a position in Ascendis Pharma A/S in Q1 2019 and has held it in 16 quarters since.
187 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2022.

Based on Comerica Bank's 13F filing for Q4 2022, filed 26 Jan 2023.